21046 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof Lyases (4)
IMMUNOTHERAPY
#2LOW DOSE LYMPHODEPLETION WITH ADOPTIVE CELL THERAPY
#3METHODS AND COMPOSITIONS FOR METHIONINE RESTRICTION
#4RIBONUCLEASES FOR TREATING VIRAL INFECTIONS
#5RECOMBINANT METHIONINASE IN THE TREATMENT OF CANCER
#6PHENYLALANINE-DEGRADING ENZYME VARIANTS AND TREATMENTS FOR PHENYLKETONURIA
#7ARTIFICIAL BLOOD SUBSTITUTES
#8ENGINEERING B CELL-BASED PROTEIN FACTORIES TO TREAT SERIOUS DISEASES
#9COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES
#10THERAPEUTIC COMPOSITIONS AND METHODS OF USING SEROTONIN MODULATING MICROBIOME-BASED INTERVENTIONS TO TREAT SEROTONIN-RELATED DISEASES OR DISORDERS
#11CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#12COMPOSITIONS AND METHODS OF TREATMENT OF DISEASE USING COMBINATION OF A NITRODILATOR AND A NITROGEN OXIDE COMPOUND
#13SUBSTITUTED PYRAZOLYL COMPOUNDS AND METHODS OF USE THEREOF
#14Viral Vectors For Treating Neurogenic Detrusor Overactivity
#15SITE-SPECIFIC BRAIN THERAPEUTICS
#16MICROBIAL SIGNATURES OF AUTISM SPECTRUM DISORDER
#17HUMAN PAH EXPRESSION CASSETTE FOR TREATMENT OF PKU BY LIVER-DIRECTED GENE REPLACEMENT THERAPY
#18Adeno-Associated Viral (AAV)-Mediated Sphingosine-1-Phosphate Lyase (SPL) Expression for Treating Pulmonary Fibrosis
#19PHARMACEUTICAL COMPOSITION, PACKAGE AND METHOD FOR PRODUCING THE SAME
#20Methods Of Treating Skin Cancer With Histidine Ammonia-Lyase (HAL) Agonists
#21CONJUGATES OF PHENYLALANINE AMMONIA-LYASE AND POEGMA AND METHODS FOR THEIR USE
#22ENGINEERED PROBIOTICS AND THE APPLICATIONS THEREOF
#23DEGRADATION OF TOXINS IN VIVO
#24ENGINEERED METHIONINE GAMMA LYASE VARIANTS
#25ENGINEERED MICROORGANISM FOR TREATING HYPERPHENYLALANINEMIA AND USE THEREOF
#26Modulation of Oxidative Stress and Amino Acid Metabolism for the Treatment or Prevention of Diseases and Disorders
#27Heterocyclic Carboxylate Compounds as Glycolate Oxidase Inhibitors
#28COMPOSITIONS AND METHODS FOR TREATMENT OF HOMOCYSTINURIA
#29TREATMENT OF INTERFERON DRIVEN INFLAMMATION
#30THERAPEUTIC AGENT FOR DISC HERNIATION
#31COMPOSITIONS AND METHODS FOR TREATING PHENYLKETONURIA
#32ENGINEERED PHENYLALANINE AMMONIA LYASE ENZYMES
#33USE OF LOW pH ACTIVE ALPHA-1,4;/1,6-GLYCOSIDE HYDROLASES (GLCH) AS A FEED ADDITIVE FOR RUMINANTS TO ENHANCE STARCH DIGESTION
#34AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE
#35FULL LIGHT REPAIR
#36PACKAGE AND METHOD FOR PRODUCING THE SAME
#37METHOD FOR MANAGING PAIN
#38ENHANCED EXPRESSION OF AN AROMATIC AMINO ACID DECARBOXYLASE (AADC) IN THE SUBSTANTIA NIGRA FOR THE TREATMENT OF PARKINSON'S DISEASE
#39MODULATION OF ACMSD PROTEIN EXPRESSION
#40Viral Vectors For Treating Neurogenic Detrusor Overactivity
#41CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#42CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#43BACTERIA ENGINEERED TO TREAT DISORDERS IN WHICH OXALATE IS DETRIMENTAL
#44Viral Vectors For Treating Neurogenic Detrusor Overactivity
#45CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#46PHARMACEUTICAL COMPOSITIONS COMPRISING RANPIRNASE
#47METHOD AND COMPOSITION FOR THE TREATMENT OF CANCER
#48Compositions and methods for treatment of homocystinuria
#49Heterocyclic carboxylate compounds as glycolate oxidase inhibitors
#50Treatment Of Homocystinuria And Hyperhomocysteinemia Using Cystathionine-Gamma-Lyase
#51TYPE I DIABETES THERAPY
#52Compositions and Methods for Controlled Protein Degradation in Neurodegenerative Disease
#53METHOD AND COMPOSITION FOR TREATING ARGINASE 1 DEFICIENCY
#54NEIL2 PROTEIN THERAPY FOR TREATMENT OF VIRAL INFECTION
#55VESICLES COMPRISING A PTEN INHIBITOR AND USES OF SAME
#56ENGINEERED LEUCINE DECARBOXYLASES
#57APPLICATION OF MICROBIAL GLYCOSIDASE AS AN ANTI-VIRAL THERAPEUTIC, PROGNOSTIC, AND DIAGNOSTIC
#58Pharmaceutical composition, package and method for producing the same
#59METHODS FOR ENGINEERING AMINO ACID AMMONIA LYASE ENZYMES AND ENZYMES THEREBY OBTAINED
#60MICROBIAL CONSORTIA
#61VIRAL VECTORS FOR TREATING NEUROGENIC DETRUSOR OVERACTIVITY
#62ADVANCED MICROBIOME THERAPEUTICS ENGINEERED TO PRODUCE SEROTONIN IN VIVO
#63IN VIVO USE OF CHONDROITINASE AND/OR HYALURONIDASE TO ENHANCE DELIVERY OF AN AGENT
#64CHONDROITINASE ABC MUTANTS AND METHODS OF MANUFACTURE AND USE THEREOF
#65CARBONIC ANHYDRASE II COMPOSITIONS AND METHODS OF USE THEREOF
#66Methods for Treating Parkinson's Disease
#67COMPOSITIONS AND METHODS FOR TREATMENT OF HOMOCYSTINURIA
#68Optimization of enzyme replacement therapy for treatment of homocystinuria
#69ENGINEERED TYROSINE AMMONIA LYASE
#70Methods of treating skin cancer with histidine ammonia-lyase (HAL) agonists
#71ENGINEERED TYROSINE AMMONIA LYASE
#72Engineered methionine gamma lyase variants
#73CRYSTALLIZED OXALATE DECARBOXYLASE AND METHODS OF USE
#74METHODS OF TREATING HYPEROXALURIA
#75Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating adolescent subjects
#76THERAPEUTIC COMPOSITIONS AND METHODS OF USING SEROTONIN MODULATING MICROBIOME-BASED INTERVENTIONS TO TREAT SEROTONIN-RELATED DISEASES OR DISORDERS
#77TREATMENT OF NOCTURNAL SYMPTOMS AND MORNING AKINESIA IN SUBJECTS WITH PARKINSON'S DISEASE
#78Synergistic Combinations of Amino Acid Depletion Agent Sensitizers (AADAS) and Amino Acid Depletion Agents (AADA), and Therapeutic Methods of Use Thereof
#79Composition for preventing age-related metabolic and tissue degenerative changes
#80HIGH EFFICIENCY OXALATE-DEGRADING ENZYMES FOR DEGRADATION OF INSOLUBLE AND SOLUBLE OXALATE
#81METHOD FOR TREATING ALZHEIMER'S DISEASE BY REGULATING AMINO ACID LEVEL
#82ENUMERATION OF GENETICALLY ENGINEERED MICROORGANISMS BY LIVE CELL COUNTING TECHNIQUES
#83CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#84COMPOSITIONS COMPRISING A TWEAK LIGAND AND METHODS OF USING SAME
#85Therapeutic agent for disc herniation
#86CRYSTALLIZED OXALATE DECARBOXYLASE AND METHODS OF USE
#87Compositions and methods for treatment of homocystinuria
#88Human PAH expression cassette for treatment of PKU by liver-directed gene replacement therapy
#89PEPTIDES AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
#90METHOD OF TREATING A MAMMAL, INCLUDING HUMAN, AGAINST CANCER USING METHIONINE AND ASPARAGINE DEPLETION
#91Repair of UV-induced DNA lesions
#92METHODS AND COMPOSITIONS FOR THE TREATMENT AND/OR PREVENTION OF TYPE 1 DIABETES
#93Method of treating AML subtypes using arginine-depleting agents
#94Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria
#95Composition or combination comprising anionic dietary supplement and 25-hydroxy vitamin D
#96Method and composition for treating neuropathic pain
#97METHODS FOR PROMOTING PANCREATIC ISLET CELL GROWTH
#98AADC polynucleotides for the treatment of Parkinson's disease
#99TREATMENT OF RETINAL DEGENERATION USING GENE THERAPY
#100Composition for the treatment of COVID-19 infection, and a method of treatment
#101FEED SUPPLEMENTS
#102RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS
#103COMPOSITIONS FOR PROTECTING SKIN COMPRISING DNA REPAIR ENZYMES AND PHYCOBILIPROTEIN
#104USE OF LOW pH ACTIVE ALPHA-1,4;/1,6-GLYCOSIDE HYDROLASES (GLCH) AS A FEED ADDITIVE FOR RUMINANTS TO ENHANCE STARCH DIGESTION
#105DECREASING IMMUNE ACTIVITY THROUGH MODULATION OF POSTCELLULAR SIGNALING FACTORS
#106Compositions containing exosome carrying NF-κB inhibitors and methods of using thereof
#107ENGINEERED TYROSINE AMMONIA LYASE
#108Orally administered composition of methioninase enzyme
#109Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#110TREATMENT OF CANCER BY GUANIDINIUM DERIVATIVES
#111CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#112Compositions and methods for the treatment of Parkinson's disease
#113STRUCTURE, MANUFACTURING AND USES OF HUMAN-DERIVED CELL-PERMEABLE PEPTIDES CONJUGATED WITH SPECIFIC BIOLOGICALLY ACTIVE CARGO PEPTIDES
#114Antimalarial enzyme conjugates, kits containing same, and methods of producing and using same
#115ENOLASE 1 (ENO1) COMPOSITIONS AND USES THEREOF
#116Methods for Inducing Intermittent Fasting and Modulating Autophagy
#117Method for managing pain
#118Heterocyclic carboxylate compounds as glycolate oxidase inhibitors
#119Methods and Compositions for Treating Phenylketonuria
#120Modulation of oxidative stress and amino acid metabolism for the treatment or prevention of diseases and disorders
#121COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF METABOLIC DESEASES AND RELATED DISORDERS
#122Vesicles comprising a PTEN inhibitor and uses of same
#123IMPROVED IMMUNOTHERAPY
#124Pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursor
#125METHODS FOR PROMOTING PANCREATIC ISLET CELL GROWTH
#126GENE SEQUENCE CONSTRUCT USED FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES
#127Pharmaceutical composition, package and method for producing the same
#128Package and method for producing the same
#129NOVEL COMPOSITION AND USE THEREOF
#130Gastroretentive treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
#131Type I diabetes therapy
#132Engineered primate cystine/cysteine degrading enzymes as antineogenic agents
#133AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS
#134Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#135Compositions and methods for treatment of homocystinuria
#136Formulations of 5-fluorocytosine and uses thereof
#137Compositions and methods for treatment of homocystinuria
#138Optimization of enzyme replacement therapy for treatment of homocystinuria
#139STABLE FORMULATIONS FOR CNS DELIVERY OF ARYLSULFATASE A
#140AN AGENT, A DEVICE AND A BLOOD-CIRCULATION SYSTEM FOR TREATING LYSOSOMAL STORAGE DISEASES, AND A METHOD FOR TREATING LYSOSOMAL STORAGE DISEASES
#141Engineered tyrosine ammonia lyase
#142Engineered anthrax protective antigen proteins for cancer therapy
#143Novel Combinations for Antigen Based Therapy
#144Crystallized oxalate decarboxylase and methods of use
#145Purification of cystathionine beta-synthase
#146CRYSTALLIZED OXALATE DECARBOXYLASE AND METHODS OF USE
#147Viral vectors for treating neurogenic detrusor overactivity
#148Polynucleotides encoding engineered tyrosine ammonia lyase variants
#149Engineered primate cystine/cysteine degrading enzymes as antineogenic agents
#150Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#151Crystallized oxalate decarboxylase and methods of use
#152COMPOSITIONS AND METHODS FOR THE TREATMENT OF CNS INJURIES
#153Glycoside hydrolases to treat biofilm-associated infections
#154Composition and methods for treating ischemic wounds and inflammatory conditions
#155Engineered primate L-methioninase for therapeutic purposes
#156Bioresponsive particles
#157Bioresponsive Particles
#158AADC polynucleotides for the treatment of Parkinson's disease
#159Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
#160AADC polynucleotides for the treatment of Parkinson's disease
#161ENOLASE 1 (ENO1) COMPOSITIONS AND USES THEREOF
#162Enolase 1 (ENO1) compositions and uses thereof
#163COMPOSITIONS AND USES THEREOF
#164IN VIVO USE OF CHONDROITINASE AND/OR HYALURONIDASE TO ENHANCE DELIVERY OF AN AGENT
#165COMPOSITION FOR ALLEVIATING OR TREATING PAIN
#166Therapeutic agent for disc herniation
#167Methods and kits for assessing Heparanase procoagulant activity, compositions comprising Heparanase, and methods for the treatment of coagulation-related disorders
#168Engineered tyrosine ammonia lyase
#169Flexible tissue matrix and methods for joint repair
#170Method and composition for treating arginase 1 deficiency
#171PEPTIDES AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
#172Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides
#173METHOD FOR MITIGATING METASTASIS
#174Compositions and methods for treatment of homocystinuria
#175Stable formulations for CNS delivery of arylsulfatase A
#176Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#177Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#178Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#179Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#180Method for delivery of biological molecule to nervous tissue
#181METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM
#182Compositions and methods for treating or preventing oxalate-related disease
#183Oral microbiota promotion for immune system associated inflammations
#184AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE
#185PURIFICATION OF CYSTATHIONINE BETA-SYNTHASE
#186COMPOSITIONS AND METHODS FOR THE TREATMENT OF AADC DEFICIENCY
#187Formulations of 5-fluorocytosine and uses thereof
#188AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE
#189AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE
#190AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE
#191Method of treating a mammal, including human, against cancer using methionine and asparagine depletion
#192COMPOSITIONS AND METHODS FOR THE TREATMENT OF AADC DEFICIENCY
#193High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate
#194Pharmaceutical kit comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursor
#195Engineered primate cystine/cysteine degrading enzymes for therapeutic uses
#196Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria
#197Compositions and methods for treatment of homocystinuria
#198METHODS FOR DIAGNOSING AND TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
#199Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
#200Staphylococcus lysin and use thereof
#201METHODS OF TREATING NEURODEGENERATIVE DISORDERS
#202Composition for treating pain
#203CRYSTALLIZED OXALATE DECARBOXYLASE AND METHODS OF USE
#204METHODS OF TREATING PARKINSON'S DISEASE USING VIRAL VECTORS
#205Crystallized oxalate decarboxylase and methods of use
#206Engineered anthrax protective antigen proteins for cancer therapy
#207Compositions for protecting skin comprising DNA repair enzymes and phycobiliprotein
#208Recombinant human ADA2 and ADA2 fusion proteins and methods for treating ADA2 deficiencies
#209Compositions for the Restoration of a Fecal Microbiota and Methods for Making and Using Them
#210Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
#211Methods of reducing extravasation of inflammatory cells
#212Propionyl-CoA carboxylase compositions and uses thereof
#213Genetically modified probiotic for the treatment of phenylketonuria (PKU) disease
#214Broad spectrum of lyase and use thereof
#215Crystallized oxalate decarboxylase and methods of use
#216FUSION PROTEINS FOR THE TREATMENT OF CNS
#217RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS
#218Compositions and methods of using chondroitinase ABCI mutants
#219BACTERIOPHAGE-CONTAINING THERAPEUTIC AGENTS
#220USE OF GENETICALLY ENGINEERED STRAIN VNP20009-M IN PREVENTING AND TREATING CANCER METASTASIS
#221HUMAN-ENZYME MEDIATED DEPLETION OF CYSTINE FOR TREATING PATIENTS WITH CYSTINURIA
#222Engineered primate L-methioninase for therapeutic purposes
#223Composition and methods for treating ischemic wounds and inflammatory conditions
#224Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
#225Method of highly expressing target protein from plant using RbcS fusion protein and method of preparing composition for oral administration of medical protein using target protein expression plant body
#226AADC polynucleotides for the treatment of parkinson's disease
#227Compositions and methods for the treatment of phenylketonuria (PKU)
#228Compositions for the Restoration of a Fecal Microbiota and Methods for Making and Using Them
#229Compositions and methods for treatment of homocystinuria
#230Thermally stable enzymes, compositions thereof and method of using same
#231Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#232Use of Allene Oxide Synthase for Semen Preservation and Assisted Reproduction
#233Use of 15 male fertility related proteins or combination thereof
#234Methods of treating neurodegenerative disorders
#235Recombinant AAV vectors useful for reducing immunity against transgene products
#236Polynucleotides encoding engineered tyrosine ammonia lyase variants
#237Acellular bioabsorbable tissue regeneration matrices
#238Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#239PROTEOGLYCAN DEGRADING MUTANTS FOR TREATMENT OF CNS
#240Methods and compositions for treating phenylketonuria
#241Near-infrared light-activated proteins
#242Chemically modified cystathionine β-synthase enzyme for treatment of homocystinuria
#243Engineered primate L-methioninase for therapeutic purposes
#244Compositions and methods of using chondroitinase ABCI mutants
#245ENOLASE 1 (ENO1) COMPOSITIONS AND USES THEREOF
#246Compositions and methods of using chondroitinase ABCI mutants
#247Polymer particles and uses thereof
#248Therapeutic agent for disc herniation
#249COMPOSITIONS COMPRISING ENO1 AND THEIR USE IN METHODS OF TREATING OBESITY OR OVERWEIGHT AND REDUCING WEIGHT GAIN
#250Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
#251Treatment of retinal degeneration using gene therapy
#252Therapeutic hyperbranched polyglycerol encapsulated biomolecules
#253Method of treatment using a pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and its cofactor
#254Materials and methods for nerve grafting
#255Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation related disorders
#256Compositions and methods for promoting neuronal outgrowth
#257METHODS OF TREATING PARKINSON'S DISEASE USING VIRAL VECTORS
#258Formulations of 5-fluorocytosine and uses thereof
#259ALGINATE AND ALGINATE LYASE COMPOSITIONS AND METHODS OF USE
#260METHOD FOR TREATING ALS VIA THE INCREASED PRODUCTION OF FACTOR H
#261Purification of cystathionine beta-synthase
#262Compositions, methods, and devices for dialysis
#263Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides
#264Compositions And Methods For Heparan Sulfate As A Biomarker For Transplant Rejection
#265Cycle adenosine monophosphate-incompetent adenylyl cyclase and compositions and methods for treating heart failure and increasing cardiac function
#266Enzyme conjugate and prodrug cancer therapy
#267Compositions and methods for treatment of homocystinuria
#268Crystallized oxalate decarboxylase and methods of use
#269Methods of treating neurodegenerative conditions
#270Methods and compositions for the treatment and/or prevention of type 1 diabetes
#271Formulations of Antimicrobial, Antiviral, and Antineoplastic Compounds In Combination With Certain Wavelengths of Light
#272Antibodies to argininosuccinate synthase and related methods
#273Enolase 1 (Eno1) compositions and uses thereof
#274Compositions and Methods for Treating Complications Associated with Diabetes
#275Enolase 1 (Eno1) compositions and uses thereof
#276METHODS FOR TREATMENT OF CORONARY HEART DISEASE EVENTS BASED ON LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 ACTIVITY
#277Crystallized oxalate decarboxylase and methods of use
#278Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
#279METHOD AND COMPOSITION FOR TREATING SPASTICITY
#280Treatment of bone diseases
#281Engineered tyrosine ammonia lyase
#282FUSION PROTEINS FOR THE TREATMENT OF CNS
#283Agents for the prevention and/or treatment of central nervous system damage
#284Genetically-Modified Probiotic for Treatment of Phenylketonuria
#285GENETICALLY MODIFIED PROBIOTIC FOR THE TREATMENT OF PHENYLKETONURIA (PKU) DISEASE
#286Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
#287Methods of treating cancer of the central nervous system
#288Compositions and methods of using chondroitinase ABCI mutants
#289PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING TYPE I DIABETES AND APPLICATION THEREOF
#290Compositions and methods for oxalate reduction
#291Regulator of complement activation and uses thereof
#292Therapeutic agent for disc herniation
#293Engineered primate cystine/cysteine degrading enzymes as antineogenic agents
#294Engineered primate L-methioninase for therapeutic purposes
#295Orally administered plastid expressed cholera toxin B subunit-exendin 4 as treatment for type 2 diabetes
#296Compositions and methods for promoting neuronal outgrowth
#297Crystallized oxalate decarboxylase and methods of use
#298Method of treating or retarding the development of blindness
#299Treatments for gastrointestinal disorders
#300Factor H for transplantation